Bendamustine versus chlorambucil for the first-line treatment of chronic lymphocytic leukemia in England and Wales: a cost-utility analysis

Beth Woods; N. Hawkins; W. Dunlop; A. O'Toole; S. Bramham-Jones

doi:10.1016/j.jval.2012.03.1389

Bendamustine versus chlorambucil for the first-line treatment of chronic lymphocytic leukemia in England and Wales: a cost-utility analysis

Beth Woods, N. Hawkins, W. Dunlop, A. O'Toole, S. Bramham-Jones

Centre for Health Economics

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	759-770
Number of pages	12
Journal	Value in Health
Volume	15
Issue number	5
DOIs	https://doi.org/10.1016/j.jval.2012.03.1389
Publication status	Published - 2012

Access to Document

10.1016/j.jval.2012.03.1389

Cite this

@article{304d37fad2d1437f879a009f92748055,

title = "Bendamustine versus chlorambucil for the first-line treatment of chronic lymphocytic leukemia in England and Wales: a cost-utility analysis",

author = "Beth Woods and N. Hawkins and W. Dunlop and A. O'Toole and S. Bramham-Jones",

year = "2012",

doi = "10.1016/j.jval.2012.03.1389",

language = "English",

volume = "15",

pages = "759--770",

journal = "Value in Health",

issn = "1098-3015",

publisher = "Elsevier",

number = "5",

}

TY - JOUR

T1 - Bendamustine versus chlorambucil for the first-line treatment of chronic lymphocytic leukemia in England and Wales

T2 - a cost-utility analysis

AU - Woods, Beth

AU - Hawkins, N.

AU - Dunlop, W.

AU - O'Toole, A.

AU - Bramham-Jones, S.

PY - 2012

Y1 - 2012

U2 - 10.1016/j.jval.2012.03.1389

DO - 10.1016/j.jval.2012.03.1389

M3 - Article

SN - 1098-3015

VL - 15

SP - 759

EP - 770

JO - Value in Health

JF - Value in Health

IS - 5

ER -